Europe Faces Rapid Spread of a New Influenza Variant

A newly identified influenza strain is swiftly making its way across Europe, triggering alertness among healthcare experts. Originating in Italy, this highly virulent flu variant is now approaching France, leading to increased caution throughout the region.

Introduction of the “Australian flu” into European regions

In October, a 76-year-old patient in Italy was admitted under urgent conditions, marking the first recorded European case of this novel influenza variant. Since then, sporadic cases have emerged in Lombardy, Lazio (the area around Rome), and Piedmont. This influenza subtype is thought to be a derivative of the H3N2 virus from the A strain, commonly seen in the Southern Hemisphere.

Termed the “Australian flu” by epidemiologists, this nickname reflects its significant impact in Australia, where it triggered the second most severe flu epidemic in recent history. This title underscores its origin and the serious health consequences it poses.

Add Cosmo Herald as a Preferred Source

The transmission pattern of this flu resembles other worrisome viral incidents, such as those discussed in alarming chimp behavior that could have led to a pandemic, emphasizing the need for constant surveillance of new health threats.

Unique characteristics and symptoms

This flu strain stands out for its increased severity compared to typical seasonal influenza. Professor Fabrizio Pregliasco, Health Director at IRCCS Galeazzi and a virology expert at the University of Milan, notes that this variant possesses notable "immune-evasion" capabilities, allowing it to bypass parts of the body’s immune defense.

The illness commonly presents with a range of symptoms including:

Rapid onset of high fever exceeding 38°C
Respiratory issues like nasal congestion or a runny nose
Muscle and joint aches
Dry coughing
Reduced appetite
Chills coupled with headaches
Fatigue and bone discomfort
Gastrointestinal disturbances such as vomiting and diarrhea

Of particular concern are neurological effects seen predominantly in elderly patients. These can involve mental fog, confusion, and, rarely, encephalitis—a serious brain inflammation with potentially fatal outcomes.

Guidelines for prevention and care

Although symptoms generally resolve within 4-7 days, some cases may experience prolonged illness lasting up to two weeks. Recovery relies heavily on adequate rest and hydration. Fever and pain relief should be managed with medical supervision.

Vaccination remains a cornerstone of prevention. The tetravalent flu vaccine is effective against the Australian flu variant and is advised for high-risk groups such as seniors, immunocompromised people, and individuals with chronic health conditions.

Epidemiologist Massimo Ciccozzi from the University Campus Bio-Medico recommends:

Age GroupAdvice60-65 years and olderReceive tetravalent vaccineAt-risk individualsPrioritize immunizationGeneral publicAdhere to health protocols

Additionally, maintaining good overall health can support immune function. For example, proper hydration habits are vital for strengthening the body’s defenses.

Predicted transmission and outlook

While various H3N2 subtypes commonly circulate in France during winters, this specific Australian flu subtype has yet to be confirmed there. Its potential arrival and spread are closely linked to weather conditions.

Scientists warn that an early, prolonged cold period could increase the incidence of this flu strain, whereas variable temperatures might encourage circulation of other respiratory viruses such as adenovirus, rhinovirus, metapneumovirus, or even COVID-19.

As the flu season nears, public health officials stress the importance of prevention efforts, not only through vaccination but also by practicing enhanced hygiene. For instance, awareness of hidden microbial hotspots within bathrooms can help limit virus spread.

Experts advise caution without panic, noting that isolated incidents do not indicate an outbreak. Ongoing surveillance is essential for tracking and managing this emerging influenza strain.

Researchers continue to investigate novel treatments to fight viral infections. Recent findings, such as those revealing new uses for approved drugs in brain disease therapy, show promise for innovative strategies against health challenges including evolving flu strains.